请选择 进入手机版 | 继续访问电脑版
设为首页收藏本站

老西部英语

 找回密码
 立即注册

只需一步,快速开始

[大学生论坛]:新癌症治疗的高成本 - 所有国家的不平等挑战

7

主题

7

资源

38

积分

新手上路

Rank: 1

积分
38
小J 发表于 2019-1-4 09:29:57 | 显示全部楼层 |阅读模式
本帖最后由 小J 于 2019-1-4 09:40 编辑

The High Cost of New Cancer Therapies—A Challenge of Inequality for All Countries

When people orgovernments cannot afford effective and potentially life-saving orlife-prolonging treatments, we usually think of this situation affectinglow-resource countries in the Third World.
我们通常会认为人们或政府无法承担高效的能拯救生命或延长生命的治疗这种情况会影响第三世界的少资源国家。

When antiretroviral HIVmedications increased life expectancy almost to normal throughout much of theworld, hundreds of thousands died in African countries, in part due to the highcost of medications.
当抗逆转录病毒药物治疗提高了世界大部分地区的预期寿命到正常水平,但是在非洲国家,有数十万人死亡的部分原因是药物的高成本。

Ford et al1 in 2011 stated, “Early concernsabout the cost and complexity of treatment were overcome thanks to the effortsof a global coalition of health providers, activists, academics, and peopleliving with HIV/AIDS, who argued that every effort must be made to ensureaccess to essential care when millions of lives depended on it.”
福特等人在2011年说过:“由于卫生服务提供者的全球联盟,活动家、学者和艾滋病毒携带者/艾滋病患者的努力,所以对于早期治疗的成本和复杂性的担忧已经被克服。他们认为必须尽一切努力来确保获得基本照护。

The authors alsoreferred to an important court case in Thailand in 2002, in which 2 patientswith HIV won the case against Bristol-Myers-Squibb to override the patent of anantiretroviral drug; thus, much cheaper generics could be produced.
作者还提到了2002年一桩发生在泰国的重要案件:两名艾滋病毒感染者战胜了百时美施贵宝,推翻了抗逆转病毒药物的专利,因此,许多更便宜的仿制药产生了。

Patents can lead to high prices and limitaccess to medications; consequently, patients are “injured” by high prices,which can challenge the legality of high prices.
专利可以导致高价格和限制药物的使用;因此,患者会因为高价格而“受伤”,这可能会对高价格的合法性提出质疑。

The ruling had great internationalimplications both for health care and human rights.
这项裁决对医疗保健和人权都有重大的国际影响

From

JAMA NetworkViewpoint September 2017

友荐云推荐
评论

使用道具 举报


QQ|关于我们|联系我们|网络条款|建议反馈|小黑屋|老西部英语 ( 版权所有 粤ICP备11103350号  

GMT+8, 2019-3-24 23:27 , Processed in 0.143865 second(s), 30 queries .

Powered by Discuz! X3

© 2001-2013 Comsenz Inc.